Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    respiratory

    Pulmonary nodules

    Also known as: Lung nodules, Solitary pulmonary nodule, Multiple pulmonary nodules, Subsolid pulmonary nodules, Ground-glass nodules

    Pulmonary nodules are small, focal opacities identified via thoracic imaging. While many represent benign inflammatory lesions, others may indicate early-stage malignancy. Clinical assessment is predicated on radiological morphology, temporal growth patterns, and individual risk factors; management protocols range from serial surveillance to biopsy or surgical resection. A diagnostic meta-analysis suggests integrated liquid-biopsy models may assist future stratification, though these do not supersede specialist assessment. A trial protocol for herbal medicine is noted, though efficacy data are currently unavailable, and evidence regarding acupuncture is absent. In clinical practice, Chinese medicine may be utilised as individualised adjunctive support for associated symptomatology or psychological distress. It is not indicated for the reduction of nodule volume or oncological prophylaxis. Traditional patterns describe symptomatic presentations rather than radiological findings; asymptomatic nodules do not necessitate a TCM pattern diagnosis.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Adhere to all scheduled computed tomography (CT) surveillance and specialist consultations, ensuring a personal copy of the surveillance protocol is maintained.
    • •Access smoking cessation support and eliminate exposure to secondary tobacco smoke.
    • •Minimise inhalation of avoidable particulates, fumes, and atmospheric pollutants through the use of occupational controls and adherence to environmental air-quality advisories.
    • •Maintain nutritional consistency, adequate sleep hygiene, and moderate physical activity; seek psychological support if surveillance-related anxiety impairs daily functioning.

    Cautions & Contraindications

    See sources
    • •Do not defer CT surveillance, biopsy, surgery or oncology referral while trying acupuncture or herbs. The supplied herbal protocol retains guideline-based surveillance and clinically indicated standard care in both groups.[]
    • •Do not present the listed formulas as proven to prevent progression: the supplied trial tests a different formulation and reports no efficacy results. Its protocol cannot establish safety or effectiveness for these formulas.[]
    • •Before biopsy, surgery or systemic treatment, disclose all herbal products and coordinate any withholding with the treating team. Pregnancy, anticoagulation, thrombocytopenia, immunosuppression and liver or kidney impairment require individual safety review; these are general precautions, not safety findings established by the supplied trial protocol.[]
    • •Do not use probiotics, antibiotics or microbiota interventions specifically to prevent nodule malignancy on the basis of the supplied mechanistic review; it does not establish clinical benefit for that purpose.[]

    When to reassess or seek care again

    See sources

    Review any symptom-directed adjunctive care after 2–4 weeks, recording cough frequency, 0–10 symptom distress, sleep disruption, functional tolerance and adverse effects. Stop or modify care if there is no meaningful benefit or adverse effects develop. Confirm that the medical surveillance plan remains in place; CT timing is determined by the treating team, not the adjunctive review interval. Escalate new symptoms promptly and reported imaging progression to the respiratory specialist; symptom improvement is not a surrogate for nodule stability.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP · 2026
    2. JMIR research protocols · 2026
    3. Microbiological research · 2026
    4. International journal of women's health · 2026

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.